Roivant Sciences Ltd.
ROIV72
$12.30arrow_drop_up0.90%$0.11
ROIV72
$12.30
arrow_drop_up0.90%Performance History
| Key Stats | |
|---|---|
| Open | $12.18 |
| Prev. Close | $12.19 |
| EPS | 5.95 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 11.99 | 12.42 |
| 52 Week Range | 8.24 | 13.24 |
| Ratios | |
|---|---|
| EPS | 5.95 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Roivant Sciences Ltd. (ROIV)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Matthew Gline
- Headquarters
- London
- Employees
- 904
- Exchange
- NASDAQ
Keep an eye on Roivant Sciences Ltd.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Roivant Sciences Ltd.'s (ROIV) price per share?
The current price per share for Roivant Sciences Ltd. (ROIV) is $12.3. The stock has seen a price change of $0.11 recently, indicating a 0.9% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Roivant Sciences Ltd. (ROIV)?
For Roivant Sciences Ltd. (ROIV), the 52-week high is $13.24, which is 7.64% from the current price. The 52-week low is $8.24, the current price is 49.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Roivant Sciences Ltd. (ROIV) a growth stock?
Roivant Sciences Ltd. (ROIV) has shown an average price growth of 0.41% over the past three years. It has received a score of 85 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Roivant Sciences Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Roivant Sciences Ltd. (ROIV) stock price performance year to date (YTD)?
As of the latest data, Roivant Sciences Ltd. (ROIV) has a year-to-date price change of 8.37%. Over the past month, the stock has experienced a price change of 19.07%. Over the last three months, the change has been 15.82%. Over the past six months, the figure is 6.31%.
help
Is Roivant Sciences Ltd. (ROIV) a profitable company?
Roivant Sciences Ltd. (ROIV) has a net income of $4.23B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 87.53% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -402.44% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $124.8M, although specific revenue growth data is currently not available. The gross profit is $109.24M. Operating income is noted at $4.24B. Furthermore, the EBITDA is -$1.02B.
help
What is the market capitalization of Roivant Sciences Ltd. (ROIV)?
Roivant Sciences Ltd. (ROIV) has a market capitalization of $9.1B. The average daily trading volume is 4.09M, indicating the stock's liquidity and investor engagement.
News
ANALYST RATINGS
5/31/2024The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
5/30/2024
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates
EARNINGS RELEASES AND OPERATING RESULTS
5/30/2024Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
5/20/2024
Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
CALENDAR OF EVENTS
CONFERENCE CALLS/ WEBCASTS
5/16/2024Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
ANALYST RATINGS
4/22/2024Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know